Louis-David Cantin

Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s

Valérie Campagna-Slater, Nicolas Moitessier, Joshua Pottel, 2012, J. Chem. Inf. Model..

Mitigating the Inhibition of Human Bile Salt Export Pump by Drugs: Opportunities Provided by Physicochemical Property Modulation, In Silico Modeling, and Structural Modification

Louis-David Cantin, Daniel J. Warner, Tobias Noeske, 2012, Drug Metabolism and Disposition.

Virtual screening and computational optimization for the discovery of covalent prolyl oligopeptidase inhibitors with activity in human cells.

Nicolas Moitessier, Louis-David Cantin, Lucienne Juillerat-Jeanneret, 2012, Journal of medicinal chemistry.

Design and synthesis of MMP inhibitors using N-arylsulfonylaziridine hydroxamic acids as constrained scaffolds

Stephen Hanessian, Nicolas Moitessier, Louis-David Cantin, 2001 .

Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors.

Louis-David Cantin, Lawrence C Kuo, Ralph Hirschmann, 2003, Journal of medicinal chemistry.